Literature DB >> 29355170

Renal physiology: TRPC5 inhibition to treat progressive kidney disease.

Jenny van der Wijst1, René J M Bindels1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29355170     DOI： 10.1038/nrneph.2018.4

Source DB:  PubMed          Journal:  Nat Rev Nephrol        ISSN： 1759-5061            Impact factor:   28.314


× No keyword cloud information.
  10 in total

1.  Antagonistic regulation of actin dynamics and cell motility by TRPC5 and TRPC6 channels.

Authors:  Dequan Tian; Sarah M P Jacobo; David Billing; Anete Rozkalne; Steven D Gage; Theodora Anagnostou; Hermann Pavenstädt; Hermann Pavenstaedt; Hsiang-Hao Hsu; Johannes Schlondorff; Arnolt Ramos; Anna Greka
Journal:  Sci Signal       Date:  2010-10-26       Impact factor: 8.192

2.  TRPC6 is a glomerular slit diaphragm-associated channel required for normal renal function.

Authors:  Jochen Reiser; Krishna R Polu; Clemens C Möller; Peter Kenlan; Mehmet M Altintas; Changli Wei; Christian Faul; Stephanie Herbert; Ivan Villegas; Carmen Avila-Casado; Mary McGee; Hikaru Sugimoto; Dennis Brown; Raghu Kalluri; Peter Mundel; Paula L Smith; David E Clapham; Martin R Pollak
Journal:  Nat Genet       Date:  2005-05-27       Impact factor: 38.330

3.  TRPC5 Does Not Cause or Aggravate Glomerular Disease.

Authors:  Xuexiang Wang; Ranadheer R Dande; Hao Yu; Beata Samelko; Rachel E Miller; Mehmet M Altintas; Jochen Reiser
Journal:  J Am Soc Nephrol       Date:  2017-10-23       Impact factor: 10.121

4.  Heteromeric channels formed by TRPC1, TRPC4 and TRPC5 define hippocampal synaptic transmission and working memory.

Authors:  Jenny Bröker-Lai; Astrid Kollewe; Barbara Schindeldecker; Jörg Pohle; Vivan Nguyen Chi; Ilka Mathar; Raul Guzman; Yvonne Schwarz; Alan Lai; Petra Weißgerber; Herbert Schwegler; Alexander Dietrich; Martin Both; Rolf Sprengel; Andreas Draguhn; Georg Köhr; Bernd Fakler; Veit Flockerzi; Dieter Bruns; Marc Freichel
Journal:  EMBO J       Date:  2017-08-08       Impact factor: 11.598

Review 5.  TRPC6 channel as an emerging determinant of the podocyte injury susceptibility in kidney diseases.

Authors:  Daria V Ilatovskaya; Alexander Staruschenko
Journal:  Am J Physiol Renal Physiol       Date:  2015-06-17

6.  A mutation in the TRPC6 cation channel causes familial focal segmental glomerulosclerosis.

Authors:  Michelle P Winn; Peter J Conlon; Kelvin L Lynn; Merry Kay Farrington; Tony Creazzo; April F Hawkins; Nikki Daskalakis; Shu Ying Kwan; Seth Ebersviller; James L Burchette; Margaret A Pericak-Vance; David N Howell; Jeffery M Vance; Paul B Rosenberg
Journal:  Science       Date:  2005-05-05       Impact factor: 47.728

7.  A small-molecule inhibitor of TRPC5 ion channels suppresses progressive kidney disease in animal models.

Authors:  Yiming Zhou; Philip Castonguay; Eriene-Heidi Sidhom; Abbe R Clark; Moran Dvela-Levitt; Sookyung Kim; Jonas Sieber; Nicolas Wieder; Ji Yong Jung; Svetlana Andreeva; Jana Reichardt; Frank Dubois; Sigrid C Hoffmann; John M Basgen; Mónica S Montesinos; Astrid Weins; Ashley C Johnson; Eric S Lander; Michael R Garrett; Corey R Hopkins; Anna Greka
Journal:  Science       Date:  2017-12-08       Impact factor: 47.728

8.  Inhibition of the TRPC5 ion channel protects the kidney filter.

Authors:  Thomas Schaldecker; Sookyung Kim; Constantine Tarabanis; Dequan Tian; Samy Hakroush; Philip Castonguay; Wooin Ahn; Hanna Wallentin; Hans Heid; Corey R Hopkins; Craig W Lindsley; Antonio Riccio; Lisa Buvall; Astrid Weins; Anna Greka
Journal:  J Clin Invest       Date:  2013-11-15       Impact factor: 14.808

Review 9.  Genetic testing for nephrotic syndrome and FSGS in the era of next-generation sequencing.

Authors:  Elizabeth J Brown; Martin R Pollak; Moumita Barua
Journal:  Kidney Int       Date:  2014-03-05       Impact factor: 10.612

10.  Podocyte injury in diabetic nephropathy: implications of angiotensin II-dependent activation of TRPC channels.

Authors:  Daria V Ilatovskaya; Vladislav Levchenko; Andrea Lowing; Leonid S Shuyskiy; Oleg Palygin; Alexander Staruschenko
Journal:  Sci Rep       Date:  2015-12-10       Impact factor: 4.379
  10 in total
  5 in total

Review 1.  Canonical transient receptor potential channels and their modulators: biology, pharmacology and therapeutic potentials.

Authors:  Yuan-Yuan Gao; Wen Tian; Hui-Nan Zhang; Yang Sun; Jing-Ru Meng; Wei Cao; Xiao-Qiang Li
Journal:  Arch Pharm Res       Date:  2021-03-24       Impact factor: 4.946

Review 2.  Nephrin Signaling in the Podocyte: An Updated View of Signal Regulation at the Slit Diaphragm and Beyond.

Authors:  Claire E Martin; Nina Jones
Journal:  Front Endocrinol (Lausanne)       Date:  2018-06-05       Impact factor: 5.555

Review 3.  Abnormal Crosstalk between Endothelial Cells and Podocytes Mediates Tyrosine Kinase Inhibitor (TKI)-Induced Nephrotoxicity.

Authors:  Xiaoying Gu; Su Zhang; Ti Zhang
Journal:  Cells       Date:  2021-04-12       Impact factor: 6.600

Review 4.  Therapeutic trials in adult FSGS: lessons learned and the road forward.

Authors:  An S De Vriese; Jack F Wetzels; Richard J Glassock; Sanjeev Sethi; Fernando C Fervenza
Journal:  Nat Rev Nephrol       Date:  2021-05-20       Impact factor: 28.314

Review 5.  Remarkable Progress with Small-Molecule Modulation of TRPC1/4/5 Channels: Implications for Understanding the Channels in Health and Disease.

Authors:  Aisling Minard; Claudia C Bauer; David J Wright; Hussein N Rubaiy; Katsuhiko Muraki; David J Beech; Robin S Bon
Journal:  Cells       Date:  2018-06-01       Impact factor: 6.600
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.